Research

Without research, there would be no progress. Research is therefore crucial to providing better care for patients both now and into the future. Associate Professor Grummet believes that it is the practising urological surgeon who is in the best position to lead clinical urological research.

The experience of daily clinical practice shows us where patient care is lacking and leads us to question how we might improve it. With the exponential rise of technological advances and the power of collaboration, we now have the opportunity to make great strides forward in a short period of time.

Inspired by the clinical research he experienced at The Prostate Centre at Vancouver General Hospital, A/Prof Grummet has since presented widely and published on his research projects. His areas of interest have been on the benefits of surgical treatment of high risk prostate cancer and on active surveillance for low risk prostate cancer.

Recognising that most of the controversies surrounding prostate cancer start with its diagnosis, A/Prof Grummet has now turned his research focus onto prostate cancer diagnostics including MRI and biopsy, and supervises Master of Surgery and Bachelor of Medical Science researchers in this field. Topics under investigation include the risk of biopsy sepsis, diagnostic accuracy, the role of MRI-targeted biopsy, and PSMA PET scanning.

A/Prof Grummet and his research students have created one of the world's largest, high quality granular databases on prostate MRI.


Publications – Peer Reviewed

Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.

Moris L, Cumberbatch MG, Van den Broeck T, Gandaglia G, Fossati N, Kelly B, Pal R, Briers E, Cornford P, De Santis M, Fanti S, Gillessen S, Grummet JP, Henry AM, Lam TBL, Lardas M, Liew M, Mason MD, Omar MI, Rouvière O, Schoots IG, Tilki D, van den Bergh RCN, van Der Kwast TH, van Der Poel HG, Willemse PM, Yuan CY, Konety B, Dorff T, Jain S, Mottet N, Wiegel T. Eur Urol. 2020 Mar 4. pii: S0302-2838(20) 30071-3.

"TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now.

Grummet J, Gorin MA, Popert R, O'Brien T, Lamb AD, Hadaschik B, Radtke JP, Wagenlehner F, Baco E, Moore CM, Emberton M, George AK, Davis JW, Szabo RJ, Buckley R, Loblaw A, Allaway M, Kastner C, Briers E, Royce PL, Frydenberg M, Murphy DG, Woo HH. Prostate Cancer Prostatic Dis. 2020 Mar; 23(1): 62-65.

EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).

Lam TBL, MacLennan S, Willemse PM, Mason MD, Plass K, Shepherd R, Baanders R, Bangma CH, Bjartell A, Bossi A, Briers E, Briganti A, Buddingh KT, Catto JWF, Colecchia M, Cox BW, Cumberbatch MG, Davies J, Davis NF, De Santis M, Dell'Oglio P, Deschamps A, Donaldson JF, Egawa S, Fankhauser CD, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Gross T, Grummet JP, Henry AM, Ingels A, Irani J, Lardas M, Liew M, Lin DW, Moris L, Omar MI, Pang KH, Paterson CC, Renard-Penna R, Ribal MJ, Roobol MJ, Rouprêt M, Rouvière O, Sancho Pardo G, Richenberg J, Schoots IG, Sedelaar JPM, Stricker P, Tilki D, Vahr Lauridsen S, van den Bergh RCN, Van den Broeck T, van der Kwast TH, van der Poel HG, van Leenders GJLH, Varma M, Violette PD, Wallis CJD, Wiegel T, Wilkinson K, Zattoni F, N'Dow JMO, Van Poppel H, Cornford P, Mottet N. Eur Urol. 2019 Dec; 76(6): 790-813.

Detection and localisation of primary prostate cancer using 68 Ga-PSMA PET/CT compared with mpMRI and radical prostatectomy specimens.

Kalapara AA, Nzenza T, Pan HY, Ballok Z, Ramdave S, O'Sullivan R, Ryan A, Cherk M, Hofman MS, Konety BR, Lawrentschuk N, Bolton D, Murphy DG, Grummet JP, Frydenberg M. BJU Int. 2019 Jul 1. doi: 10.1111/bju.14858.

Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations.

Van den Broeck T, van den Bergh RCN, Briers E, Cornford P, Cumberbatch M, Tilki D, De Santis M, Fanti S, Fossati N, Gillessen S, Grummet JP, Henry AM, Lardas M, Liew M, Mason M, Moris L, Schoots IG, van der Kwast T, van der Poel H, Wiegel T, Willemse PM, Rouvière O, Lam TB, Mottet N. Eur Urol Focus. 2020 Mar 15; 6(2): 231-234.


Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial.

Bowden P, See AW, Frydenberg M, Haxhimolla H, Costello AJ, Moon D, Ruljancich P, Grummet J, Crosthwaite A, Pranavan G, Peters JS, So K, Gwini SM, McKenzie DP, Nolan S, Smyth LML, Everitt C. Int J Cancer. 2020 Jan 1; 146(1): 161-168.

Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.

Van den Broeck T, van den Bergh RCN, Arfi N, Gross T, Moris L, Briers E, Cumberbatch M, De Santis M, Tilki D, Fanti S, Fossati N, Gillessen S, Grummet JP, Henry AM, Lardas M, Liew M, Rouvière O, Pecanka J, Mason MD, Schoots IG, van Der Kwast TH, van Der Poel HG, Wiegel T, Willemse PM, Yuan Y, Lam TB, Cornford P, Mottet N.
Eur Urol. 2019 Jun; 75(6): 967-987.

A review of the safety and efficacy of inhaled methoxyflurane as an analgesic for outpatient procedures.

Jephcott C, Grummet J, Nguyen N, Spruyt O.
Br J Anaesth. 2018 May; 120(5):1040-1048.

 

Can Video Conferencing Facilitate Better Discharge Processes and a Superior Patient Experience?

Grummet J, Wickramasinghe N, Haddad P, O'Connor L.
Stud Health Technol Inform. 2017; 245:1360.

 

How to Biopsy: Transperineal Versus Transrectal, Saturation Versus Targeted, What's the Evidence?

Grummet J.
Urol Clin North Am. 2017 Nov; 44(4):525-534.

 

Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.

Mottet N, De Santis M, Briers E, Bourke L, Gillessen S, Grummet JP, Lam TB, van der Poel HG, Rouvière O, van den Bergh RCN, Cornford P.
Eur Urol. 2017 Nov 2. pii: S0302-2838(17)30839-4.

 

Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer.

Hansen NL, Barrett T, Kesch C, Pepdjonovic L, Bonekamp D, O'Sullivan R, Distler F, Warren A, Samel C, Hadaschik B, Grummet J, Kastner C.
BJU Int. 2018 Jul; 122(1):40-49.

 

Transperineal vs. transrectal biopsy in MRI targeting.

Grummet J, Pepdjonovic L, Huang S, Anderson E, Hadaschik B.
Transl Androl Urol. 2017 Jun; 6(3):368-375.

 

Prostate Cancer Management in an Ageing Population.

Grummet JP, Plass K, N'Dow J.
Eur Urol. 2017 Oct; 72(4):532-533.

 

Effect of triptorelin on lower urinary tract symptoms in Australian prostate cancer patients.

Woo HH, Murphy DG, Testa GM, Grummet JP, Chong M, Stork AP.
Res Rep Urol. 2017 Feb 23; 9:27-35.

 

Re: Marco Borghesi, Hashim Ahmed, Robert Nam, et al. Complications After Systematic, Random, and Image-guided Prostate Biopsy. Eur Urol 2017;71:353-65.

Grummet J, Pepdjonovic L, Moon D.
Eur Urol. 2017 May; 71(5):e143-e144.

 

Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches.

Roberts MJ, Bennett HY, Harris PN, Holmes M, Grummet J, Naber K, Wagenlehner FME.
Urology. 2017 Jun;104:11-21.

 

Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis.

Pepdjonovic L, Tan GH, Huang S, Mann S, Frydenberg M, Moon D, Hanegbi U, Landau A, Snow R, Grummet J.
World J Urol. 2017 Aug; 35(8):1199-1203.

 

Planning for the post-antibiotic era - why we must avoid TRUS-guided biopsy sampling.

Murphy DG, Grummet JP.
Nat Rev Urol. 2016 Oct; 13(10):559-60.

 

The who, when and how of PSA testing: new Australian Guidelines

Grummet J.
Medicine Today 2016; 17(6): 55-57.

 

Risk factors for infection following prostate biopsy

Anderson E, Leahy O, Cheng AC, Grummet J.
BMC Infect Dis. 2015 Dec 23;15(1): 580.

 

Current practice of prostate biopsy in Australia and New Zealand: A survey.

Davis P, Paul E, Grummet J.
Urol Ann. 2015: Jul-Sep; 7(3): 315-9.

 

The state of TRUS biopsy sepsis in Australia: Re-admissions to Victorian Hospitals with TRUS biopsy-related infection over 5 years.

Roth H, Millar J, Cheng A, Byrne A, Evans S, Grummet J.
BJU Int. 2015: Oct;116 Suppl 3:49-53. doi: 10.1111/bju13209.

 

Could MRI solve the prostate cancer conundrum?

Grummet J, O'Sullivan R.
Med J Aust 2015 May 4; 202(8): 410-11.
 


A high PSA level in a man with suspected prostatitis. It's just due to inflammation, right?

Grummet J.
Medicine Today 2015; 16(5); 61-62.


 

Significant impact of transperineal template biopsy of the prostate at a single tertiary institution.

Huang S, Reeves F, Preece J, Satasivam P, Royce P, Grummet J.
Urology Annals 2015: Oct-Dec;7(4):428-32.

 


Penthrox alone versus Penthrox plus PILA for analgesia in TRUS-guided prostate biopsy.

Huang S, Pepdjonovic L, Konstantatos A, Frydenberg M, Grummet J.
ANZ J Surg 2015 Feb 5. doi: 10.1111/ans.12974.

 

Transperineal biopsy prostate cancer detection in first biopsy and post-negative TRUS biopsy settings: The Victorian Transperineal Biopsy Collaboration experience.

Ong WL, Weerakoon M, Huang S, Paul E, Lawrentschuk N, Frydenberg M, Moon D, Murphy D, Grummet J.
BJU Int. 2015 Oct;116(4):568-76. doi: 10.1111/bju.13031.

 

TRUS biopsy sepsis and the rise of carbapenem antibiotic use.

Leahy O, O'Reilly M, Phillips D, Dyer D, Grummet J.
ANZ J Surg 2014 Dec;85(12):931-5. doi: 10.1111/ans.12933.

 

Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?

Grummet JP, Weerakoon M, Huang S, Lawrentschuk N, Frydenberg M, Moon DA, O'Reilly M, Murphy D.
BJU Int. 2014 Sep;114(3):384-8.

*This paper received the BJUI Global Prize and was measured as one of the top 20 publications in Urology in 2014-5.

 

Is zero sepsis alone enough to justify transperineal prostate biopsy?

Murphy DG, Weerakoon M, Grummet J. 
BJU Int. 2014 Jul;114(1):3-4.

 

Trans-perineal prostate biopsy: template-guided or free-hand? 

Dundee PE, Grummet J, Murphy DG
BJU Int. 2014 May;115(5):681-3. doi: 10.1111/bju.12860.

 

A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.

Clark AK, Taubenberger AV, Taylor RA, Niranjan B, Chea ZY, Zotenko E, Sieh S, Pedersen JS, Norden S, Frydenberg M, Grummet JP, Pook DW; Australian Prostate Cancer BioResource, Stirzaker C, Clark SJ, Lawrence MG, Ellem SJ, Hutmacher DW, Risbridger GP.
Biomaterials. 2013 Jul;34(20):4777-85.

 

The 'green whistle': a novel method of analgesia for transrectal prostate biopsy.

Grummet J, Huang S, Konstantatos A, Frydenberg M.
BJU Int. 2012 Dec;110 Suppl 4:85-8.

 

Radical prostatectomy for high-risk clinically localized prostate cancer: a prospective single institution series.

Koupparis AJ, Grummet JP, Hurtado-Coll A, Bell RH, Buchan N, Goldenberg SL, Gleave ME.
Can Urol Assoc J. 2011 Dec;5(6):E156-61.

 

Paraneoplastic syndromes in prostate cancer.

Hong MK, Kong J, Namdarian B, Longano A, Grummet J, Hovens CM, Costello AJ, Corcoran NM.
Nat Rev Urol. 2010 Dec;7(12):681-92.

 

Vesicourethral anastomosis with 2-octyl cyanoacrylate adhesive in an in vivo canine model.

Grummet JP, Costello AJ, Swanson DA, Stephens LC, Cromeens DM.
Urology. 2002 Nov;60(5):935-8.

 

Laser welded vesicourethral anastomosis in an in vivo canine model: a pilot study.

Grummet JP, Costello AJ, Swanson DA, Stephens LC, Cromeens DM.
J Urol. 2002 Jul;168(1):281-4.


Publications – Abstracts up to 2014

2014

 

Transperineal biopsy streamlined.

Grummet J., Mann S., Grummet H., Murphy D.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 140), 2014. Date of Publication: March 2014.

 

Zero sepsis in 331 consecutive transperineal biopsies.

Grummet J., Weerakoon M., Huang S., Lawrentschuk N., Frydenberg M., Moon D., Murphy D.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 64), 2014. Date of Publication: March 2014.

 

Pathological outcomes of transperineal biopsy of the prostate - The Victorian Transperineal Biopsy Collaboration (VTBC) experience.

Ong W.L., Weerakoon M., Huang S., Lawrentschuk N., Frydenberg M., Moon D., Murphy D., Grummet J.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 39), 2014. Date of Publication: March 2014.

 

Analysis of outcomes and impact on clinical management with Transperineal Template Biopsy.

Huang S., Reeves F., Preece J., Satasivam P., Grummet J.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 118-119), 2014. Date of Publication: March 2014.

 

The state of TRUS biopsy sepsis. Re-admissions to all Victorian hospitals with TRUS biopsy infection over 5 years.

Roth H., Millar J., Cheng A., Byrne A., Evans S., Grummet J.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 42), 2014. Date of Publication: March 2014.

 

Comparison of two novel methods of TRUS biopsy analgesia: Methoxyflurane alone versus methoxyflurane plus local anaesthetic infiltration.

Ong W.L., Huang S., Pepdjonovic L., Konstantantos A., Frydenberg M., Grummet J.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 18-19), 2014. Date of Publication: March 2014.

 

Pathology of renal cell carcinoma in the state of Victoria.

Satasivam P., Rao K., Reeves F., Basto M., Ivey Z., Yip M., Roth H., Grummet J., Goad J., Appu S., Kearsley J., Moon D., Murphy D., Lawrentschuk N., Costello A., Bolton D., Frydenberg M.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 132-133), 2014. Date of Publication: March 2014.

 

Choosing the best surgical approach for T1b renal cell carcinoma.

Satasivam P., Reeves F., Rao K., Ivey Z., Basto M., Yip M., Roth H., Grummet J., Goad J., Moon D., Murphy D., Appu S., Lawrentschuk N., Bolton D., Kearsley J., Costello A., Frydenberg M.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 132), 2014. Date of Publication: March 2014.

 

The effect of clinical stage and lesion complexity on the practice of surgery for renal cell carcinoma in the state of Victoria.

Satasivam P., Rao K., Reeves F., Ivey Z., Basto M., Yip M., Roth H., Grummet J., Goad J., Moon D., Murphy D., Appu S., Kearsley J., Lawrentschuk N., Costello A., Bolton D., Frydenberg M.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 132), 2014. Date of Publication: March 2014. 

 

The presence of risk factors for chronic kidney disease may diminish the benefit of partial nephrectomy for renal cell carcinoma.

Satasivam P., Rao K., Reeves F., Basto M., Ivey Z., Yip M., Roth H., Grummet J., Goad J., Appu S., Kearsley J., Moon D., Murphy D., Lawrentschuk N., Costello A., Bolton D., Frydenberg M.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 42-43), 2014. Date of Publication: March 2014.

 

The adoption of routine pelvic lymphadenectomy may be associated with improved overall survival in patients undergoing radical cystectomy for bladder cancer.

Satasivam P., Roth H., Kerr S., Sivarajah G., Grummet J., Goad J., Brennan J.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 131), 2014. Date of Publication: March 2014.

 

Phase II study of neoadjuvant 'supercastration' in men with high-risk prostate cancer.

Corcoran N., Howard N., Bugeja P., Kerger M., Moon D., Clarke D., Grummet J., Hovens C., Costello T., Pedersen J., Ryan A., Ruljancich P., Parente P.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 18), 2014. Date of Publication: March 2014.

 

Epidemiology and contemporary management of traumatic bladder ruptures at an Australian major trauma centre.

Yao H.H.I., Grummet J., Esser M., Atkin C., Hanegbi U.

BJU International. Conference: 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Brisbane, QLD Australia. Conference Start: 20140316 Conference End: 20140319. Conference Publication: (var.pagings). 113 (pp 29), 2014. Date of Publication: March 2014.


2013

TRUS biopsy sepsis and use of carbapenem antibiotics at a single high volume local institution.

Leahy O., O'Reilly M., Phillips D., Grummet J.

BJU International. Conference: Prostate Cancer World Congress and 14th Australasian Prostate Cancer Conference Melbourne, VIC Australia. Conference Start: 20130806 Conference End: 20130810. Conference Publication: (var.pagings). 112 (pp 26-27), 2013. Date of Publication: August 2013.

 

Sepsis and superbugs: Should transperineal biopsy be offered to all prospective prostate biopsy patients?

Grummet J., Weerakoon M., Huang S., Lawrentschuk N., Frydenberg M., Moon D., O'Reilly M., Murphy D.

BJU International. Conference: Prostate Cancer World Congress and 14th Australasian Prostate Cancer Conference Melbourne, VIC Australia. Conference Start: 20130806 Conference End: 20130810. Conference Publication: (var.pagings). 112 (pp 26), 2013. Date of Publication: August 2013.

 

Transperineal template biopsy of the prostate: A review of the impact at Alfred Health.

Huang S., Reeves F., Preece J., Grummet J.

BJU International. Conference: Prostate Cancer World Congress and 14th Australasian Prostate Cancer Conference Melbourne, VIC Australia. Conference Start: 20130806 Conference End: 20130810. Conference Publication: (var.pagings). 112 (pp 25-26), 2013. Date of Publication: August 2013.

 

Transperineal prostate biopsy: A comparison of two techniques.

Grummet J., Reeves F., Frydenberg M.

BJU International. Conference: 66th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Melbourne, VIC Australia. Conference Start: 20130413 Conference End: 20130416. Conference Publication: (var.pagings). 111 (pp 99), 2013. Date of Publication: April 2013.

 

Current practices of prostate biopsy in Australia and New Zealand - the survey.

Grummet J., Davis P.

BJU International. Conference: 66th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Melbourne, VIC Australia. Conference Start: 20130413 Conference End: 20130416. Conference Publication: (var.pagings). 111 (pp 96), 2013. Date of Publication: April 2013.

 

Evaluating Netwit and its usefulness in serving the purpose to connect all urologists within Australia.

Ow D., Woo H., Grummet J., Pokorny M.R., Lawrentschuk N.

BJU International. Conference: 66th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Melbourne, VIC Australia. Conference Start: 20130413 Conference End: 20130416. Conference Publication: (var.pagings). 111 (pp 86-87), 2013. Date of Publication: April 2013.

 

Primary apocrine adenocarcinoma of scrotum suspected as urothelial carcinoma metastasis: A clinical and pathological dilemma.

Huang S., Frydenberg M., Pham A., Pedersen J., Grummet J.

BJU International. Conference: 66th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Melbourne, VIC Australia. Conference Start: 20130413 Conference End: 20130416. Conference Publication: (var.pagings). 111 (pp 118), 2013. Date of Publication: April 2013.

 

Radical cystectomy: The benefit of lymph node density.

Pirpiris A., Rzetelski-West K., Grummet J.

BJU International. Conference: 66th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Melbourne, VIC Australia. Conference Start: 20130413 Conference End: 20130416. Conference Publication: (var.pagings). 111 (pp 70), 2013. Date of Publication: April 2013.


2012

The green whistle: A novel method of analgesia for transrectal prostate biopsy.

Grummet J., Huang S., Konstantatos A., Frydenberg M.

Asia-Pacific Journal of Clinical Oncology. Conference: Annual Scientific Meeting of the Australian and New Zealand Urogenital and Prostate: State of the Art Multi-Disciplinary Care in Urological Cancers, ANZUP 2012 Sydney, NSW Australia. Conference Start: 20120715 Conference End: 20120717. Conference Publication: (var.pagings). 8 (pp 30-31), 2012. Date of Publication: July 2012.

 

The PRIAS study in Australia: One institution's experience.

Grummet J.P., Lin M.J.

BJU International. Conference: 65th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Darwin, NT Australia. Conference Start: 20120421 Conference End: 20120424. Conference Publication: (var.pagings). 109 (pp 10-11), 2012. Date of Publication: April 2012.

 

Indications and pathological outcomes of radical cystectomy: A contemporary Australian series.

Kerr S., Satasivam P., Grummet J.

BJU International. Conference: 65th Annual Scientific Meeting of the Urological Society of Australia and New Zealand Darwin, NT Australia. Conference Start: 20120421 Conference End: 20120424. Conference Publication: (var.pagings). 109 (pp 38-39), 2012. Date of Publication: April 2012.


2010

Metastatic prostate cancer presenting as a syndrome of inappropriate antidiuretic hormone secretion.

Kong J.P.L., Bultitude M.F., Longano A., Grummet J., Corcoran N.M.

BJU International. Conference: Urological Society of Australia and New Zealand 63rd Annual Scientific Meeting Perth, WA United States. Conference Start: 20100221 Conference End: 20100224. Conference Publication: (var.pagings). 105 (pp 28), 2010. Date of Publication: February 2010.

 

Painful scrotal swelling in adolescent boys and men.

Grummet J., Frydenberg M.

Medicine Today. 11 (4) (pp 81-82), 2010. Date of Publication: April 2010.


Other Presentations

August 2012: 13th Australasian Prostate Cancer Conference, Melbourne – “Transperineal Template Biopsy of the Prostate: the Initial Alfred Experience”

October 2010: 5th Annual International Academic Week, Sir Run Run Shaw Hospital, Hangzhou, China – “Active Surveillance for Low Risk Prostate Cancer”

August 2010: 11th National Prostate Cancer Symposium, Melbourne – Co-Chair session with Dr Peter Scardino on Active Surveillance of Low Risk Prostate Cancer

March 2009: USANZ ASM, Gold Coast – “Surgery For High Risk Clinically Localised Prostate Cancer: Surgical Pathology and PSA Recurrence-Free Survival”

June 2008: CUA Annual Meeting, Edmonton, Canada - “Radical Prostatectomy for High Risk Prostate Cancer: the Vancouver Experience”; received Five Star Distinction for abstract

February 2008: Genitourinary Cancers Symposium, San Francisco, California – “Radical Prostatectomy for High Risk Prostate Cancer: the Vancouver Experience”; received Merit Award for abstract

December 2007: North West Urological Society Annual Meeting, Vancouver, Canada – “Radical Prostatectomy for High Risk Prostate Cancer: the Vancouver Experience”; also presented on “Surgery for High Risk Prostate Cancer” at sponsored symposium session; moderated Bladder Cancer session

October 2007: Western Section AUA Annual Meeting, Scottsdale, Arizona – “Radical Prostatectomy for High Risk Prostate Cancer: the Vancouver Experience”

October 2006: USANZ Annual Victorian State Meeting, Shepparton – Winner 3rd Prize Best Presentation for “Laparoscopic Partial Nephrectomy – the Royal Melbourne Hospital Experience”

March 2006: Urological Society of Australasia ASM, Brisbane – “Perks, Freebies and Incentives: Zero Ethical Responsibility?”


Clinical Trials

2015- : Principal investigator and original concept author of Painfree TRUS B, a randomised control trial comparing novel methods of pain relief for patients during prostate biopsy. Awarded competitive grant funding of nearly $600,000 from Cancer Australia and PCFA.

2014-7 : Co-investigator for the ASTROID trial, assessing a decision aid for active surveillance in patients diagnosed with low risk prostate cancer.

2014-8: Site investigator for the ENZAMET trial, a randomised control trial assessing the therapeutic effect of Enzalutamide on newly-diagnosed metastatic prostate cancer.

2013-4: Co-investigator for the Duodart and sexual dysfunction trial, an international randomized placebo-controlled study of the effects of Duodart on sexual function.

2012-4: Co-investigator for the Diphereline and LUTS study, a national observational study of the effect of LHRH agonist on LUTS in men with advanced prostate cancer.

2010- : Site investigator at Alfred Hospital site for PRIAS, an international observational study in active surveillance for prostate cancer.


Master of Surgery

2001-4: Enrolled in a Master of Surgery. Conducted full-time research in the Department of Veterinary Medicine and Surgery of University of Texas M.D. Anderson Cancer Center in Houston, Texas in 2001. The techniques of laser tissue welding and use of biological adhesives were investigated for performing the anastomosis (join) between the bladder and urethra in radical prostatectomy. The longer-term follow-up project was conducted at University of Melbourne Department of Veterinary Science.

The thesis, entitled Novel Techniques for Vesico-Urethral Anastomosis in Radical Prostatectomy, was accepted and the degree of Master of Surgery conferred in 2004.